ViroPharma to Present at the BIO CEO & Investor Conference

Wednesday, February 6, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

EXTON, Pa., Feb. 5 ViroPharma Incorporated(Nasdaq: VPHM) today announced that Vincent Milano, chief financial officerand chief operating officer of ViroPharma, will present at the BIO CEO &Investor Conference at 12:30 P.M. ET on Monday, February 11, 2008. Theconference is being held at the Waldorf=Astoria, in New York.

ViroPharma's presentation will be webcast live for investors throughwww.viropharma.com and available through February 28, 2008.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to thedevelopment and commercialization of products that address serious diseasestreated by physician specialists and in hospital settings. ViroPharmacommercializes Vancocin(R), approved for oral administration for treatment ofantibiotic-associated pseudomembranous colitis caused by Clostridium difficileand enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the packageinsert at http://www.viropharma.com/docs/Vancocin_pi_2007.htm). ViroPharmacurrently focuses its drug development activities in viral diseases includingcytomegalovirus (CMV) and hepatitis C (HCV). For more information onViroPharma, visit the company's website at www.viropharma.com.

SOURCE ViroPharma Incorporated


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store